Hims & Hers: Will the Canada Expansion and Diagnostic Deal Bring about a Trend Reversal?

Telemedicine player scales its GLP-1 business with Canada launch and diagnostic acquisition Stock poised for potential trend reversal – Regulation and Novo deal remain key factors Hims & Hers Health is a US telemedicine platform offering digital treatments for issues ranging from hair loss to sexual and mental health, as well as weight management, delivering medications directly to consumers. Over the past two years, the focus has clearly shifted towards obesity: Programs centered around GLP-1-based weight loss medications like semaglutide...